Triple
T17354343
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Office of Rare Diseases Research |
E421895
|
entity |
| Predicate | parentAgency |
P254
|
FINISHED |
| Object | National Center for Advancing Translational Sciences |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: National Center for Advancing Translational Sciences | Statement: [Office of Rare Diseases Research, parentAgency, National Center for Advancing Translational Sciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: National Center for Advancing Translational Sciences Context triple: [Office of Rare Diseases Research, parentAgency, National Center for Advancing Translational Sciences]
-
A.
National Center for Advancing Translational Sciences
chosen
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
B.
National Center for Research Resources
The National Center for Research Resources was a former U.S. National Institutes of Health (NIH) center that funded and supported the development of research tools, technologies, and resources for the biomedical research community.
-
C.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
-
D.
Office of Translational Sciences
The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
-
E.
National Institutes of Health
The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d889d520008190a26917a95bf1c2ea |
completed | April 10, 2026, 5:25 a.m. |
| NER | Named-entity recognition | batch_69e43a2f26548190a8822b2470ec3c72 |
completed | April 19, 2026, 2:13 a.m. |
Created at: April 10, 2026, 5:44 a.m.